Search results
Results from the WOW.Com Content Network
[13] [16] There are far fewer studies evaluating the side effects of 5α-reductase inhibitors in women. However, due to the known role of DHT in male sexual differentiation, 5α-reductase inhibitors may cause birth defects such as ambiguous genitalia in the male fetuses of pregnant women. As such, they are not used in women during pregnancy. [36]
Treatment of men with very high-dosage DHT (a non-aromatizable androgen), which resulted in an increase in DHT levels by approximately 10-fold and complete suppression of testosterone and estradiol levels, showed that none of the measures of sexual function were significantly changed with the exception of a mild but significant decrease in ...
The suprachiasmatic nucleus is also known to be larger in men than in women. [39] An analysis of the hypothalamus by Swaab and Hofman (1990;2007) found that the volume of the SCN in homosexual men was 1.7 times larger than a reference group of male subjects, and contained 2.1 times as many cells.
5-ARIs are clinically used in the treatment of conditions that are exacerbated by DHT: [3] Mild-to-moderate benign prostatic hyperplasia and lower urinary tract symptoms; Pattern hair loss in both men and women; 5-ARIs can be used in the treatment of hirsutism in women. [1] The usefulness of 5-ARIs for the potential treatment of acne is uncertain.
Enter: DHT blockers — hair loss treatments that either cut down the levels of DHT in your body or inhibit the effects of DHT at the scalp level. Not all DHT blockers are created equally though.
Sex differences in medicine include sex-specific diseases or conditions which occur only in people of one sex due to underlying biological factors (for example, prostate cancer in males or uterine cancer in females); sex-related diseases, which are diseases that are more common to one sex (for example, breast cancer and systemic lupus erythematosus which occur predominantly in females); [1 ...
Risk Factors for Hair Loss in Women. There are quite a few risk factors for hair loss in women. They include: Age. FPHL usually develops around midlife and continues to progress as you get older.
5αR2 is expressed in specific tissues and catalyzes the transformation of testosterone (T) to 5α-dihydrotestosterone (DHT). DHT plays a key role in the process of sexual differentiation in the external genitalia and prostate during the development of the male fetus. 5αR2D is a result of impaired 5αR2 activity resulting in decreased DHT levels.